Dabigatran vs Empagliflozin

Dabigatran vs Empagliflozin: Overview

This comparison examines the pharmacological differences between Dabigatran and Empagliflozin.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Empagliflozin — 12.4 hours.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3; Empagliflozin — C23H27ClO7.

Molecular Weight: Dabigatran — 471.5100 g/mol; Empagliflozin — 450.9100 g/mol.

Type: Dabigatran — Small molecule; Empagliflozin — Small molecule.